Sanofi SA mentioned the U.S. Food and Drug Administration has authorised its Altuviiio drug, a as soon as weekly therapy for hemophilia A.
The French pharmaceutical firm
SAN,
mentioned that is the primary approval of the drug, beforehand known as efanesoctocog alfa, and that regulatory submission within the European Union is predicted within the second half of this yr.
The FDA had granted precedence overview to the drug in August and designed it a breakthrough remedy in May.
Write to Adria Calatayud at adria.calatayud@dowjones.com
Source web site: www.marketwatch.com
